Key result
Statins appear to improve biomarkers in human pulmonary arterial hypertension, but current studies are too preliminary to determine clinical relevance.
Why the study?
Do statins improve biomarkers and physiological function in patients with pulmonary arterial hypertension?
Do statins improve biomarkers and physiological function in patients with pulmonary arterial hypertension?
While statins improve biomarkers in PAH, current evidence is insufficient to support their routine clinical use for physiological improvement.
No takes yet. Share an insight, caveat, or question.
Does not support routine statin use in PAH; leaves open whether biomarker gains translate to clinical benefit.
Katsiki et al. (2011) conducted a review in Pulmonary arterial hypertension (PAH). Statins was evaluated. Statins appear to improve biomarkers in human pulmonary arterial hypertension, but current studies are too preliminary to determine clinical relevance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: